| 发明名称 |
PROCESS FOR PREPARATION OF AMORPHOUS FORM OF DASATINIB |
| 摘要 |
A stable amorphous form of dasatinib of Formula (I) wherein amorphous dasatinib after exposure to a relative humidity of 75% at 40° C. or 60% at 25° C. for a period of at least three months doesn't change to crystalline form and a process for the preparation of the amorphous form of dasatinib of Formula (I).; |
| 申请公布号 |
US2014343073(A1) |
申请公布日期 |
2014.11.20 |
| 申请号 |
US201414223862 |
申请日期 |
2014.03.24 |
| 申请人 |
CADILA HEALTHCARE LIMITED |
发明人 |
DWIVEDI SHRIPRAKASH DHAR;SINGH KUMAR KAMLESH;SINGH NIKHIL AMAR;PATIL AMOL KASHINATH |
| 分类号 |
C07D417/12 |
主分类号 |
C07D417/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A stable amorphous form of dasatinib of Formula (I)wherein amorphous dasatinib after exposure to a relative humidity of 75% at 40° C. or 60% at 25° C. for a period of at least three months doesn't change to crystalline form. |
| 地址 |
Gujarat IN |
